Insight Molecular Diagnostics (IMDX)
Develops molecular diagnostic tests for transplant rejection and oncology therapy programs.
$4.14
After hours+0.03 (+0.73%)
At close$4.11(+2.49%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.24
Revenue estimate
$215.1K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.93−$0.26−$0.30−$0.34−$0.72−$0.12−$0.31Pending
Estimate−$0.40−$0.24−$0.23−$0.21−$0.24−$0.26−$0.25−$0.24
Surprise−382.0%−9.5%−30.4%−61.9%−203.2%+54.1%−22.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.5M$2.1M$518.0K$260.0K$1.1M$32.0K$239.0KPending
Estimate$101.7K$127.5K$292.5K$283.9K$285.0K$229.2K$352.5K$215.1K
Surprise+1,361.6%+1,576.9%+77.1%−8.4%+299.6%−86.0%−32.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.06 | — | — |
| Sep 2028 | −$0.10 | — | — |
| Jun 2028 | −$0.13 | — | — |
| Mar 2028 | −$0.15 | — | — |
| Dec 2027 | −$0.20 | — | — |
| Sep 2027 | −$0.21 | — | — |
| Jun 2027 | −$0.22 | — | — |
| Mar 2027 | −$0.24 | — | — |
| Dec 2026 | −$0.23 | — | — |
| Nov 2026 | −$0.24 | — | — |
| Aug 2026 | −$0.25 | −$0.31 | −22.1% |
| May 2026 | −$0.26 | −$0.12 | +54.1% |
| Mar 2026 | −$0.24 | −$0.72 | −203.2% |
| Nov 2025 | −$0.21 | −$0.34 | −61.9% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.06 | — | — | $9.0M | — | — | — |
| Sep 2028 | −$0.10 | — | — | $7.0M | — | — | — |
| Jun 2028 | −$0.13 | — | — | $5.0M | — | — | — |
| Mar 2028 | −$0.15 | — | — | $4.0M | — | — | — |
| Dec 2027 | −$0.20 | — | — | $2.6M | — | — | — |
| Sep 2027 | −$0.21 | — | — | $1.5M | — | — | — |
| Jun 2027 | −$0.22 | — | — | $785.5K | — | — | — |
| Mar 2027 | −$0.24 | — | — | $303.7K | — | — | — |
| Dec 2026 | −$0.23 | — | — | $447.3K | — | — | — |
| Nov 9, 2026 | −$0.24 | — | — | $215.1K | — | — | — |
| Aug 10, 2026 | −$0.25 | −$0.31 | −22.1% | $352.5K | $239.0K | −32.2% | −7.1% |
| May 13, 2026 | −$0.26 | −$0.12 | +54.1% | $229.2K | $32.0K | −86.0% | +25.9% |
| Mar 26, 2026 | −$0.24 | −$0.72 | −203.2% | $285.0K | $1.1M | +299.6% | −13.4% |
| Nov 10, 2025 | −$0.21 | −$0.34 | −61.9% | $283.9K | $260.0K | −8.4% | +10.7% |
| Aug 14, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 12, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Jul 29, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 25, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 14, 2019 | |||||||
| Apr 1, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Apr 2, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 14, 2017 | |||||||
| Apr 28, 2017 | |||||||
| Feb 27, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 16, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 16, 2015 | |||||||
| Aug 14, 2015 |